Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 13, 2023
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
[ Mon, Nov 13th 2023
] - WOPRAI
Sun, November 12, 2023
[ Sun, Nov 12th 2023
] - WOPRAI
Fri, November 10, 2023
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
[ Fri, Nov 10th 2023
] - WOPRAI
Serge Belanger Maintained (VRCA) at Strong Buy with Decreased Target to $8 on, Nov 10th, 2023
Serge Belanger of Needham, Maintained "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy with Decreased Target from $10 to $8 on, Nov 10th, 2023.
Serge has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Serge's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Serge
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Thursday, October 12th, 2023
- Gregory Renza of "RBC Capital" Maintained at Buy with Increased Target to $14 on, Tuesday, July 25th, 2023
